Awny Samaan Botros Farajallah
CIK: 0002121389
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Farajallah Awny Samaan Botros
Farajallah Awny Samaan Botros (SEC CIK 0002121389) files insider reports with the SEC as Chief Medical Officer of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 3 ownership filings by Farajallah Awny Samaan Botros (1 Form 3, 2 Form 4), filed between Apr 6, 2026 and Aug 12, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Farajallah Awny Samaan Botros's filings is in CAMBRIDGE, MA.
Recent filings by Farajallah Awny Samaan Botros
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit
- Pignagnoli Agosti Marcello, Head, Strat. & Port. Dev